PG

Peter Ghoroghchian

CEO

Latus Bio

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Latus Bio
Industry
research
Employees
28.0
Seniority
C suite

Technologies

Mimecast Outlook Microsoft Office 365 Amazon AWS Zendesk Webflow Mobile Friendly Vimeo

Keywords

biotechnology research gene therapy precision delivery aav technology cns treatment therapeutic genes novel capsid variants potency immunogenicity toxicology high throughput screening disease-specific targeting one-time gene therapy tissue-specific administration huntingtons disease parkinsons disease genetic hearing loss pediatric applications clinical techniques cell-specific targeting treatment paradigms patient quality of care side effects reduction improved efficacy toxic payload delivery lysomal storage disorders neurodegenerative diseases cross-correction therapy brain microvascular targeting healthcare innovation administration routes caregiver support biotechnology advancements clinical research high-potency treatments patient outcomes neutralized immune responses therapeutic candidates disease modification healthcare equity clinical efficacy genetic interventions translational medicine leading scientists medical professionals research publications partner collaborations development pipeline rehabilitation therapies innovative medicines

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans